Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Arch Dermatol Res ; 307(3): 199-209, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25539991

ABSTRACT

This article provides an overview of pharmacology, toxicity, pharmacokinetics and clinical data of Polypodium leucotomos L. (PL). PL aerial part has proven to exert antioxidant, photoprotective and immunomodulatory activities; its mechanism of action is complex and includes several activities: (1) PL diminishes the production of reactive oxygen and nitrogen species (ROS, RNS); (2) PL inhibits the photoisomerization of trans-urocanic acid (t-UCA); (3) PL inhibits apoptosis induced by ultraviolet radiation; (4) PL prevents damage to genetic material and (5) PL enhances DNA repair. PL is not mutagenic and does not induce acute or chronic toxicity. Its biological effects have been proved in cell cultures, animal models, murine models and in human beings. Photoprotective activity has been assessed in healthy volunteers as well as in patients suffering from several cutaneous diseases such as vitiligo, psoriasis, idiopathic photodermatosis or melasma. PL results to be an efficient treatment especially for sensitive cutaneous phototypes and adds extra protection when ultraviolet radiation (UVR) exposure cannot be avoided, such as wide or narrow band UVB phototherapy or treatment with psoralens plus UVA exposure radiation.


Subject(s)
Phytotherapy , Plant Extracts/therapeutic use , Polypodium , Skin Diseases/prevention & control , Skin/drug effects , Animals , Clinical Trials as Topic , DNA Repair/drug effects , Disease Models, Animal , Humans , Mice , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Polypodium/immunology , Skin/immunology , Skin Diseases/etiology , Ultraviolet Rays/adverse effects , Urocanic Acid/analogs & derivatives , Urocanic Acid/metabolism
2.
J Biomed Biotechnol ; 2010: 398312, 2010.
Article in English | MEDLINE | ID: mdl-20625485

ABSTRACT

Nigella sativa L. (NS) has been used for medicinal purposes since ancient times. This study aimed to investigate the cytotoxicity of NS dry methanolic extract on cultured cortical neurons and its influence on neurotransmitter release, as well as the presence of excitatory (glutamate and aspartate) and inhibitory amino acids (gamma-aminobutyric acid-GABA-and glycine) in NS extract. Cultured rat cortical neurons were exposed to different times and concentrations of NS dry methanolic extract and cell viability was then determined by a quantitative colorimetric method. NS did not induce any toxicity. The secretion of different amino acids was studied in primary cultured cortical neurons by high-performance liquid chromatography (HPLC) using a derivation before injection with dansyl chloride. NS modulated amino acid release in cultured neurons; GABA was significantly increased whereas secretion of glutamate, aspartate, and glycine were decreased. The in vitro findings support the hypothesis that the sedative and depressive effects of NS observed in vivo could be based on changes of inhibitory/excitatory amino acids levels.


Subject(s)
Amino Acids/metabolism , Neurons/drug effects , Neurons/metabolism , Neurotransmitter Agents/metabolism , Plant Extracts/pharmacology , Seeds/chemistry , Animals , Cell Survival/drug effects , Cells, Cultured , Methanol , Neurons/cytology , Potassium Chloride/pharmacology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...